Published 3 years ago

Medicare copays for new Alzheimer's drug could reach $11,500

Summary by Star Tribune

0 Articles

All

Left

Center

Right

Yahoo News

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday. The drug, called Aduhelm, was approved by the Food and Drug Administration only this week. It's the first Alzheimer's medication in nearly 20 years, though it doesn't cure the life-sapping neurological condition.

3 years ago·Los Angeles, United States

Read Full Article

Associated Press News

Medicare copays for new Alzheimer's drug could reach $11,500

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

3 years ago·United States

Read Full Article

abc News

Medicare copays for new Alzheimer's drug could reach $11,500

A new report says the $56,000 Alzheimer’s drug approved this week would raise Medicare premiums broadly

3 years ago·United States

Read Full Article

The Mercury news

Medicare copays for new Alzheimer’s drug could reach $11,500

By Ricardo Alonso-Zaldivar and Matthew Perrone | Associated PressWASHINGTON — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.The drug, called Aduhelm, was approved by the Food and Drug Administration this week and quickly sparked controversy over its price-tag and que…

3 years ago·San Jose, United States

Read Full Article

npr

Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually

Some advisors to the Food and Drug Administration have quit over the drug which critics say has questionable benefits. The FDA said it can reduce clumps of plaque in the brain and may slow dementia.(Image credit: Biogen via AP)

3 years ago·Washington, United States

Read Full Article

Star Tribune

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

3 years ago·Minneapolis, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.